منابع مشابه
Management of abdominal sepsis--a paradigm shift?
The abdomen is the second most common source of sepsis and secondary peritonitis. The most common causes of abdominal sepsis are perforation, ischemic necrosis or penetrating injury to the abdominal viscera. Management consists of control of the infection source, restoration of gastrointestinal tract (GI) function, systemic antimicrobial therapy and support of organ function. Mortality after se...
متن کاملParadigm Shift
A paradigm shift, suggested by Thomas Kuhn [1], is not just a small change in science, or the modification of a theory. It is a scientific revolution and completely changes the way in which science looks at the world. It often dictates how the public looks at the world. For example, Darwin's theories [2] were intensely debated by scientists and theologians. This debate spilled over into the pub...
متن کاملParadigm shift in head and neck oncology patient management
OBJECTIVE This article describes a paradigm shift in what is considered to be good care for patients living with and after (head and neck) cancer. HNO patients often experience severe and difficult physical and psychosocial problems due to the nature and location of the disease. Many disciplines are involved in their treatment, so their voice is only one amongst many others in the decision maki...
متن کاملA paradigm shift in pulmonary arterial hypertension management.
Affiliations: Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA, and Dept of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. Dept of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, Bologna, Italy. Université Paris-Sud, Le Kremlin-Bicêtre, AP-HP, Service de Pneumologie, TORINO Thorax Innovation, Hôpital Bicêtr...
متن کاملChronic myeloid leukaemia: A paradigm shift in management.
In early 2000, a better understanding of the molecular biology of chronic myeloid leukaemia established a central role for enhanced tyrosine kinase activity leading to targeted therapy with imatinib mesylate. This paradigm shift in the management of this disease has improved the median survival from 8-9 years before 2000 to an estimated 25 years. Rapid research in this area along with well-desi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Cardiovascular Imaging
سال: 2017
ISSN: 1936-878X
DOI: 10.1016/j.jcmg.2016.10.013